Randomized Trial to Evaluate Therapeutic Gain by Changing Chemoradiotherapy From Concurrent-Adjuvant to Induction-Concurrent Sequence, and Radiotherapy From Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma.

Trial Profile

Randomized Trial to Evaluate Therapeutic Gain by Changing Chemoradiotherapy From Concurrent-Adjuvant to Induction-Concurrent Sequence, and Radiotherapy From Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
  • Indications Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2015 Planned End Date changed from 1 May 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
    • 20 Mar 2015 Planned End Date changed from 1 Apr 2017 to 1 May 2017 as reported by ClinicalTrials.gov record.
    • 20 Mar 2015 Planned primary completion date changed from 1 Sep 2012 to 1 May 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top